Patients with repeated supratherapeutic ingestion of APAP who developed hepatotoxicity presented with abnormal ALT levels. A history of alcoholism and an elevated creatinine level at presentation are markers of increased risk for hepatotoxicity and death. The gene discussed is GPT; the disease is alcohol dependence.